Edico Genome Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $100M

Edico Genome General Information

Description

Developer of a bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. The company's platform uses a field-programmable gate array to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate marking, and haplotype variant calling, enabling healthcare institutions to easily discover links between DNA sequence variations and human disease.

Contact Information

Website
www.edicogenome.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 12400 High Bluff Drive
  • Suite 650
  • San Diego, CA 92130
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Acquirer
Illumina
Vertical(s)
AgTech, Supply Chain Tech, TMT, Life Sciences
Corporate Office
  • 12400 High Bluff Drive
  • Suite 650
  • San Diego, CA 92130
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edico Genome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 14-May-2018 $100M Completed Generating Revenue
4. Early Stage VC (Series B) 09-May-2017 Completed Generating Revenue
3. Early Stage VC (Series A1) 17-Jul-2014 Completed Startup
2. Early Stage VC (Series A) 28-Mar-2014 $5.68M $5.68M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Edico Genome’s complete valuation and funding history, request access »

Edico Genome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A1
Series A 2,928,111 $0.001000 8% $1.94 $1.94 1x $1.94 15.86%
To view Edico Genome’s complete cap table history, request access »

Edico Genome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. The c
Other Healthcare Technology Systems
San Diego, CA
50 As of 2017

Garden City, NY
 

Brisbane, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edico Genome Competitors (32)

One of Edico Genome’s 32 competitors is Nebula Genomics, a Venture Capital-Backed company based in Garden City, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nebula Genomics Venture Capital-Backed Garden City, NY
Second Genome Formerly VC-backed Brisbane, CA
Saphetor Venture Capital-Backed Lausanne, Switzerland
PointCross Life Sciences Venture Capital-Backed Foster City, CA
Oxford Nanopore Technologies Formerly VC-backed Oxford, United Kingdom
You’re viewing 5 of 32 competitors. Get the full list »

Edico Genome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edico Genome Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axon Ventures Venture Capital Minority
Crescent Ridge Venture Capital Minority
Dell Technologies Capital Venture Capital Minority
Angel (individual) Minority
EvoNexus Accelerator/Incubator Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Edico Genome FAQs

  • When was Edico Genome founded?

    Edico Genome was founded in 2013.

  • Where is Edico Genome headquartered?

    Edico Genome is headquartered in San Diego, CA.

  • What is the size of Edico Genome?

    Edico Genome has 50 total employees.

  • What industry is Edico Genome in?

    Edico Genome’s primary industry is Other Healthcare Technology Systems.

  • Is Edico Genome a private or public company?

    Edico Genome is a Private company.

  • What is the current valuation of Edico Genome?

    The current valuation of Edico Genome is .

  • What is Edico Genome’s current revenue?

    The current revenue for Edico Genome is .

  • How much funding has Edico Genome raised over time?

    Edico Genome has raised $32.8M.

  • Who are Edico Genome’s investors?

    Axon Ventures, Crescent Ridge, Dell Technologies Capital, , and EvoNexus are 5 of 11 investors who have invested in Edico Genome.

  • Who are Edico Genome’s competitors?

    Nebula Genomics, Second Genome, Saphetor, PointCross Life Sciences, and Oxford Nanopore Technologies are some of the 32 competitors of Edico Genome.

  • When was Edico Genome acquired?

    Edico Genome was acquired on 14-May-2018.

  • Who acquired Edico Genome?

    Edico Genome was acquired by Illumina.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »